The weight loss drug market may approach almost $100 billion by the end of the decade. But in recent quarters, Novo has lost some ground to rival Eli Lilly, the maker of Mounjaro and Zepbound -- and ...
Eli Lilly holds the lead position in the weight management market right now. But Viking Therapeutics is working on a candidate that could be a game-changer. Viking is a riskier-than-average stock, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback